๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

Troglitazone, an insulin action enhancer, improves metabolic control in NIDDM patients

โœ Scribed by S. Kumar; A. J. M. Boulton; H. Beck-Nielsen; F. Berthezene; M. Muggeo; B. Persson; G. A. Spinas; S. Donoghue; S. Lettis; P. Stewart-Long; the Troglitazone study group


Book ID
110609447
Publisher
Springer
Year
1996
Tongue
English
Weight
62 KB
Volume
39
Category
Article
ISSN
0012-186X

No coin nor oath required. For personal study only.


๐Ÿ“œ SIMILAR VOLUMES


Troglitazone, an insulin action enhancer
โœ S. Kumar; A. J. M. Boulton; H. Beck-Nielsen; F. Berthezene; M. Muggeo; B. Persso ๐Ÿ“‚ Article ๐Ÿ“… 1996 ๐Ÿ› Springer ๐ŸŒ English โš– 964 KB

The effects of troglitazone, a novel thiazolidinedione, in non-insulin-dependent diabetic (NIDDM) patients were studied in a double-blind, parallel-group, placebo-controlled, dose-ranging trial. A total of 330 patients (63 % male), mean age 57 years (range 39-72), with two fasting capillary blood gl

Troglitazone, an insulin action enhancer
โœ Kumar, S.; Prange, A.; Schulze, J.; Lettis, S.; Barnett, A.H. ๐Ÿ“‚ Article ๐Ÿ“… 1998 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 107 KB ๐Ÿ‘ 2 views

The management of Type 2 diabetes mellitus with currently available oral agents may be complicated in the elderly by an increased frequency of side-effects. The effects of troglitazone, an insulin action enhancer, were studied in elderly patients with Type 2 diabetes in a double-blind, parallel-grou

Improved metabolic control and maintenan
โœ E.v. Ostermann; G. Klausmann; R. Herz ๐Ÿ“‚ Article ๐Ÿ“… 1994 ๐Ÿ› Elsevier Science ๐ŸŒ English โš– 67 KB

Wtese"rn";lm-.r~.100mn,aS~n) ake (Body Mass Ind+n tBJ.ffk 33.8 f 5.4 k& fM f SEMJJ NJDDM re.tienbl w-en included in 001 studs. All HMlc vdus imp&d ri@antJy fmk S.4 i 19% 0 7.6 \* 18%. (P = O#J3J. After 6 momb8 aJJ p.lials rcrcJwJ 011 conb;ol ad mainlsnun of chaoSed ea& aid fiknjk cubits muld be achi